Ipamorelin is described in the research literature as a selective agonist of the ghrelin receptor (also called the growth-hormone-secretagogue receptor)
Its effects concentrate in the area of administration, making it ideal for targeting specific tendons, ligaments, or muscle injuries
The distinctive characteristic of Ipamorelin is its exceptional SELECTIVITY: unlike other GHRPs (GHRP-6, GHRP-2, Hexarelin), Ipamorelin does NOT induce significant increases in prolactin, cortisol, ACTH, or aldosterone at studied therapeutic doses
Glutamate is taken up by astrocytes for metabolism, providing energy for glycogen synthesis
For many clients, this is the point in the year when it becomes easier to make a confident, informed decision about what their body needs heading into winter
For updates and corrections, email newsroom[at]stocktwits[dot]com